Home > Boards > US OTC > Biotechs > Oxford BioMedica PLC (OXBDF)

Novartis, still struggling with Kymriah manufacturing, is providing

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
georgejjl Member Profile
 
Followed By 77
Posts 11,116
Boards Moderated 0
Alias Born 04/08/04
160x600 placeholder
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist